Jaguar Health, Inc. Announces Reverse Stock Split
Key Highlights
- ➤Jaguar Health (JAGX) effects a 1-for-25 reverse stock split November 24, 2026
- ➤Reverse split aims to support compliance with Nasdaq listing standards
- ➤JAGX will trade split-adjusted on Nasdaq Capital Market under unchanged symbol
SAN FRANCISCO, CA / ACCESS Newswire / November 20, 2026 / Jaguar Health, Inc. (Nasdaq:JAGX) ("Jaguar" or the "Company") today announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock ("Common Stock"), at an exchange ratio of 1-for-25, at 12:01 am Eastern Time on Tuesday, November 24, 2026 (the "Effective Date") in order to support the Company's compliance with Nasdaq's listing standards. The Company's Common Stock will begin trading on a split-adjusted basis when the market opens on the Effective Date and will remain listed on The Nasdaq Capital Market under the symbol "JAGX". The new CUSIP number for the Company's Common Stock following the reverse stock split is 47010C839.
The effectuation of the reverse stock split follows the approval of a proposal submitted to Jaguar stockholders at the Company's November 2026 Special Meeting of Stockholders (the "Special Meeting"). This proposal is described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Special Meeting filed with the Securities and Exchange Commission (the "SEC") on October 8, 2026. Stockholders may obtain a free copy of the proxy statement and other documents filed by Jaguar with the SEC at http://www.sec.gov. The proxy statement is also available on the Company's corporate website.
Get started
Create a free account to read the full story.
